Teva Launches Generic Zyvox Injection

Teva Launches Generic Zyvox Injection
Teva Launches Generic Zyvox Injection

Teva announced the launch of Linezolid Injection, the generic version of Pfizer's Zyvox Injection.

Zyvox injection is an oxazolidinedione antibiotic indicated for the treatment of infections caused by susceptible Gram (+) bacteria: nosocomial pneumonia, community-acquired pneumonia; complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis; uncomplicated skin and skin structure infections; and vancomycin-resistant Enterococcus faecium infections.

RELATED: Antibiotic Formulations

Linezolid Injection is available as a 600mg/300mL strength as 10-count single-use flexible plastic infusion bags.

For more information call (888) 838-2872 or visit TevaGenerics.com.

Loading links....